Search Within

Michael Morris

Formats
  1. Meeting Abstract (276)
  2. Journal Article (268)
  3. Review (21)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (588)
  2. Genitourinary Oncology Service (588)
  3. Solid Tumor Oncology Division (588)
  4. Radiology, Department of (165)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (142)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (29)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (240)
  2. Journal of Nuclear Medicine (45)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (250)
  2. Society of Nuclear Medicine (45)
  3. American Association for Cancer Research (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (40)
  6. Elsevier Inc. (27)

More Publishers

Results (588)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation between radiographic progression-free survival (rPFS) and overall survival (OS): Results from PREVAIL
    Meeting Abstract

    Morris, M. J.; Beer, T. M.; Loriot, Y.; Higano, C. S.; Armstrong, A. J.; Sternberg, C. N.; De Bono, J. S.; Tombal, B. F.; Parli, T.; Bhattacharya, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • [(18)F] NaF PET/CT imaging biomarkers of progression-free survival in metastatic prostate cancer
    Meeting Abstract

    Harmon, S.; Perk, T.; Eickhoff, J. C.; Staab, M. J.; Choyke, P. L.; Dahut, W. L.; Apolo, A. B.; Humm, J.; Larson, S. M.; Morris, M. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Brennan, R.; Armenia, J.; Curtis, K. R.; Gopalan, A.; Arcila, M. E.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Morris, M. J.; Larson, S. M.; Ohlsson, M.; Joseffson, A.; Helgstrand, J. T.; Edenbrandt, L.; Oturai, P. S.; Roeder, M. A.; Bjartell, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer
    Journal Article

    Halabi, S.; Kelly, W. K.; Ma, H.; Zhou, H.; Solomon, N. C.; Fizazi, K.; Tangen, C. M.; Rosenthal, M.; Petrylak, D. P.; Hussain, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Synthesis and in vivo imaging of 16β-[18F]fluoro-5α-dihydrotestosterone in castration resistant prostate cancer
    Meeting Abstract

    Tochon-Danguy, H.; Ackermann, U.; Poniger, S.; Chan, G.; Morris, M.; Lewis, J.; Lyashchenko, S.; Scott, A.
    Internal Medicine Journal (2016)

    Fulltext@MSK | Save
  • Trial design and objectives for castration-resistant prostate cancer: Updated recommendations from the prostate cancer clinical trials working group 3
    Journal Article

    Scher, H. I.; Morris, M. J.; Stadler, W. M.; Higano, C.; Basch, E.; Fizazi, K.; Antonarakis, E. S.; Beer, T. M.; Carducci, M. A.; Chi, K. N.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
    Journal Article

    Anand, A.; Morris, M. J.; Larson, S. M.; Minarik, D.; Josefsson, A.; Helgstrand, J. T.; Oturai, P. S.; Edenbrandt, L.; Røder, M. A.; Bjartell, A.
    EJNMMI Research (2016)

    Fulltext@MSK | Save
  • Analytic validation of the automated bone scan index as an imaging biomarker to standardize quantitative changes in bone scans of patients with metastatic prostate cancer
    Journal Article

    Anand, A.; Morris, M. J.; Kaboteh, R.; Bath, L.; Sadik, M.; Gjertsson, P.; Lomsky, M.; Edenbrandt, L.; Minarik, D.; Bjartell, A.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • A molecular model for predicting overall survival in patients with metastatic clear cell renal carcinoma: Results from CALGB 90206 (Alliance)
    Journal Article

    Kim, H. L.; Halabi, S.; Li, P.; Mayhew, G.; Simko, J.; Nixon, A. B.; Small, E. J.; Rini, B.; Morris, M. J.; Taplin, M. E.; more...
    EBioMedicine (2015)

    Fulltext@MSK | Save